Virtu Financial’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Virtu Financial’s Portfolio BIOTU Stock Details BIOTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,968	Closed	-$130K	–	2467
2022 Q4	$130K	Buy	+12,968	New	+$130K	0.02%	868
2021 Q4	–	Sell	-16,804	Closed	-$169K	–	2365
2021 Q3	$169K	Buy	+16,804	New	+$168K	0.01%	968

Virtu Financial's BIOTU Position: Q1 2023 in Review

Virtu Financial sold out of Biotech Acquisition Company Unit (BIOTU) in Q1 2023, closing a stake of 12,968 shares — an estimated $130K sold.

Virtu Financial first reported a position in BIOTU in Q3 2021 and held it in 2 quarters. The position peaked at $169K in Q3 2021. 0 funds tracked by Wall St. Rank hold BIOTU as of Q1 2023.

Virtu Financial reported no remaining Biotech Acquisition Company Unit position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 12,968 Biotech Acquisition Company Unit shares in Q1 2023, an estimated $130K.
Virtu Financial first reported a position in Biotech Acquisition Company Unit in Q3 2021 and held it in 2 quarters.
Virtu Financial's Biotech Acquisition Company Unit position peaked at $169K in Q3 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.